Discover trends, market shifts, and competitive outlooks for the rare disease diagnostics industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
What Are the Key Projections for the CAGR of the Rare Disease Diagnostics Market Size From 2025 to 2034?
The market size for diagnosing rare diseases has seen robust growth in the past few years. Expected to rise from $35.23 billion in 2024 to $38.22 billion in 2025, it will achieve a compound annual growth rate (CAGR) of 8.5%. The historic growth can be linked to the surge in demand for cloud-based diagnostics, a higher emphasis on enhancing efficiency, growing incidence of neurological disease, an upswing in immunological disorders, and increased healthcare expenditure.
The market for diagnosing rare diseases is anticipated to experience significant expansion in the coming years, ballooning to a value of $56.23 billion by 2029, with a compound annual growth rate (CAGR) of 10.1%. The progression during the predicted timeframe can be ascribed to several elements including a rising number of rare disease occurrences, governmental support, the growth of hospitals and diagnostic laboratories, the surge in hematology diseases, and the expanding health care infrastructure. Foreseen trends during this period consist of breakthroughs in genetic testing methods, the launch of whole-genome and next-generation sequencing (NGS), substantial financial inputs, and strategic partnerships geared towards research exploration.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12651&type=smp
What External and Internal Drivers Are Contributing to the Growth of theRare Disease Diagnostics Market?
The rare disease diagnostics market is anticipated to expand due to the rising occurrence of rare ailments. These diseases, which are less prevalent compared to other standard illnesses, affect a small fraction of the population. Efficient treatment is enhanced by rare disease diagnostics as they assist in comprehensively managing the disease, pinpointing potential treatment options, and preventing unnecessary treatments that could result in severe side effects. For example, Health Match, a digital health organization based in Australia, reported in November 2022 that there are roughly 150 uncommon kidney diseases. These illnesses are highly prevalent worldwide, with a rate of 60–80 cases per 100,000 individuals in the United States and Europe. As such, the escalating incidence of rare diseases is fuelling the growth of the rare disease diagnostics market.
What Segment Types Define the Rare Disease Diagnostics Market Structure?
The rare disease diagnostics market covered in this report is segmented –
1) By Test Type: Genetic Test, General Lab Test, Imaging Test
2) By Technology: Capillary Sequencing, Whole Genome Sequencing, Whole Exome Sequencing, Microarrays
3) By Sample Type: Deoxyribonucleic Acid (DNA) Sample, Buccal Swab Sample, Blood, Saliva
4) By Disease Type: Gastroenterology Disease, Endocrine And Metabolism Disorders Disease, Hematology And Oncology Disease, Dermatology Disease, Cardiovascular Disorders, Neurology Disease
5) By End User: Hospital Laboratories, Diagnostics Laboratories, Genetic Testing Laboratories, Cancer Research Laboratories
Subsegments:
1) By Genetic Test: Whole Genome Sequencing, Targeted Gene Panels, Exome Sequencing, Carrier Testing
2) By General Lab Test: Blood Tests, Biochemical Assays, Urine Tests, Cytogenetic Tests
3) By Imaging Test: MRI (Magnetic Resonance Imaging), CT (Computed Tomography) Scans, Ultrasound, X-Rays
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=12651&type=smp
Which Geographic Areas Hold the Strongest Growth Potential in the Rare Disease Diagnostics Market?
North America was the largest region in the rare disease diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rare disease diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What Long-Term Trends Are Transforming the Competitive Landscape of the Rare Disease Diagnostics Market?
Innovations in technology are becoming a prominent trend within the rare disease diagnostics market. Major players in the market are adopting these advancements to maintain their market position. For example, Centogene GmbH, a German-based rare disease company, introduced CentoGenome, a whole genome sequencing solution for diagnosing rare and neurodegenerative illnesses, in April 2023. CentoGenome is an improved next-generation sequencing (NGS)-based test that provides whole genome sequencing (WGS) examinations for both rare and neurodegenerative conditions. It can detect almost all disease-triggering variants in one go. Its sensitivity in detecting Copy Number Variations (CNVs) associated with Spinal Muscular Atrophy (SMA), along with complex disease-inducing variations linked with Gaucher Disease (GD) and susceptibility to GBA1-related Parkinson’s Disease (PD), is impeccable. The integration of PCR (polymerase chain reaction)-free technology by CentoGenome in areas of the genome that are difficult to sequence will significantly reduce bias and provide high-quality sequence data. This information will offer deeper insights into coding, regulatory, and intronic regions.
View the full report here:
https://www.thebusinessresearchcompany.com/report/rare-disease-diagnostics-global-market-report
What Is the Definition of the Rare Disease Diagnostics Market?
Rare disease diagnostics refers to the process of identifying and diagnosing medical conditions that are considered rare or uncommon. These diagnostics are used for early detection and diagnosis, as well as the selection of targeted and personalized treatment plans for uncommon disorders.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12651
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
